Literature DB >> 17012803

Crystallization and preliminary X-ray diffraction analysis of Salmonella typhi PilS.

Asha M Balakrishna1, Yvonne Yih-Wan Tan, Henry Yu-Keung Mok, Anand M Saxena, Kunchithapadam Swaminathan.   

Abstract

The structure determination of PilS, a type IV pilin, by X-ray crystallography is reported. The recombinant protein from Salmonella typhi was overexpressed, purified and crystallized. The crystals belong to space group P2(1)2(1)2, with unit-cell parameters a = 77.88, b = 114.53, c = 31.75 A. The selenomethionine derivative of the PilS protein was overexpressed, purified and crystallized in the same space group. Data sets have been collected to 2.1 A resolution from the selenomethionine-derivative crystal using synchrotron radiation for multiwavelength anomalous dispersion (MAD) phasing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012803      PMCID: PMC2225195          DOI: 10.1107/S174430910603661X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  13 in total

1.  A HEX-1 crystal lattice required for Woronin body function in Neurospora crassa.

Authors:  Ping Yuan; Gregory Jedd; Desigan Kumaran; Subramanyam Swaminathan; Helen Shio; David Hewitt; Nam-Hai Chua; Kunchithapadam Swaminathan
Journal:  Nat Struct Biol       Date:  2003-04

Review 2.  Type IV pilus structure and bacterial pathogenicity.

Authors:  Lisa Craig; Michael E Pique; John A Tainer
Journal:  Nat Rev Microbiol       Date:  2004-05       Impact factor: 60.633

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding.

Authors:  B Hazes; P A Sastry; K Hayakawa; R J Read; R T Irvin
Journal:  J Mol Biol       Date:  2000-06-16       Impact factor: 5.469

6.  Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture.

Authors:  Gerald F Audette; Randall T Irvin; Bart Hazes
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

7.  The type IVB pili of Salmonella enterica serovar Typhi bind to the cystic fibrosis transmembrane conductance regulator.

Authors:  Inez S M Tsui; Cecilia M C Yip; Jim Hackett; Christina Morris
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin.

Authors:  Lisa Craig; Ronald K Taylor; Michael E Pique; Brian D Adair; Andrew S Arvai; Mona Singh; Sarah J Lloyd; David S Shin; Elizabeth D Getzoff; Mark Yeager; Katrina T Forest; John A Tainer
Journal:  Mol Cell       Date:  2003-05       Impact factor: 17.970

9.  NMR structure of a type IVb pilin from Salmonella typhi and its assembly into pilus.

Authors:  Xing-Fu Xu; Yih-Wan Tan; Lam Lam; Jim Hackett; Mingjie Zhang; Yu-Keung Mok
Journal:  J Biol Chem       Date:  2004-05-24       Impact factor: 5.157

10.  Structure of the bundle-forming pilus from enteropathogenic Escherichia coli.

Authors:  Stéphanie Ramboarina; Paula J Fernandes; Sarah Daniell; Suhail Islam; Pete Simpson; Gad Frankel; Frank Booy; Michael S Donnenberg; Stephen Matthews
Journal:  J Biol Chem       Date:  2005-09-19       Impact factor: 5.157

View more
  2 in total

Review 1.  Type IV pilin proteins: versatile molecular modules.

Authors:  Carmen L Giltner; Ylan Nguyen; Lori L Burrows
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

2.  The physical basis of type 4 pilus-mediated microcolony formation by Vibrio cholerae O1.

Authors:  Brooke A Jude; Ronald K Taylor
Journal:  J Struct Biol       Date:  2011-04-20       Impact factor: 2.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.